REPL · Categories · Downgrades
REPL - Analyst downgrades
Replimune Group Inc. (REPL) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for REPL
- Replimune downgraded by BMO Capital Markets with a new price targetBMO Capital Markets downgraded Replimune from Market Perform to Underperform and set a new price target of $1.00
- Replimune downgraded by Jefferies with a new price targetJefferies downgraded Replimune from Buy to Hold and set a new price target of $2.00
- Replimune downgraded by AnalystAnalyst downgraded Replimune from Neutral to Underweight
- Replimune downgraded by H.C. WainwrightH.C. Wainwright downgraded Replimune from Buy to Sell
- Replimune downgraded by Leerink Partners with a new price targetLeerink Partners downgraded Replimune from Outperform to Market Perform and set a new price target of $2.00
- Replimune downgraded by Wedbush with a new price targetWedbush downgraded Replimune from Outperform to Neutral and set a new price target of $2.00
- Replimune downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Replimune from Overweight to Neutral and set a new price target of $4.00
- Replimune downgraded by AnalystAnalyst downgraded Replimune from Neutral to Underweight
- Replimune downgraded by BMO Capital Markets with a new price targetBMO Capital Markets downgraded Replimune from Outperform to Underperform and set a new price target of $2.00
- Replimune downgraded by H.C. WainwrightH.C. Wainwright downgraded Replimune from Buy to Neutral
- Replimune downgraded by Barclays with a new price targetBarclays downgraded Replimune from Overweight to Equal Weight and set a new price target of $3.00
- Replimune downgraded by Leerink Partners with a new price targetLeerink Partners downgraded Replimune from Outperform to Market Perform and set a new price target of $3.00
- Replimune downgraded by Analyst with a new price targetAnalyst downgraded Replimune from Overweight to Neutral and set a new price target of $9.00
- Replimune downgraded by Wedbush with a new price targetWedbush downgraded Replimune from Outperform to Neutral and set a new price target of $4.00
- Replimune downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Replimune from Overweight to Neutral and set a new price target of $3.00